Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study

被引：0
|
作者：
Klaus Mross
Bernward Niemann
Ulrich Massing
Joachim Drevs
Clemens Unger
Rupinder Bhamra
Christine E. Swenson
机构：
[1] Albert-Ludwigs University Freiburg,Tumor Biology Center
[2] The Liposome Company,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 54卷
关键词：
Liposomal doxorubicin; Pharmacokinetics; Safety; Tolerability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：514 / 524
页数：10
相关论文
共 50 条
  • [21] Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacokinetics Study of ME-344 as a Single Agent in Patients With Refractory Solid Tumors
    Bendell, Johanna C.
    Patel, Manish R.
    Infante, Jeffrey R.
    Kurkjian, Carla D.
    Jones, Suzanne F.
    Pant, Shubham
    Burris, Howard A., III
    Moreno, Ofir
    Esquibel, Vanessa
    Levin, Wendy
    Moore, Kathleen N.
    CANCER, 2015, 121 (07) : 1056 - 1063
  • [22] Pharmacokinetics of Prednisolone at Steady State in Young Patients With Systemic Lupus Erythematosus on Prednisone Therapy: An Open-Label, Single-Dose Study
    Sagcal-Gironella, Anna Carmela P.
    Sherwin, Catherine M. T.
    Tirona, Rommel G.
    Rieder, Michael J.
    Brunner, Hermine I.
    Vinks, Alexander A.
    CLINICAL THERAPEUTICS, 2011, 33 (10) : 1524 - 1536
  • [23] A phase I, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib
    Gao, Ling
    Yamamiya, Ikuo
    Pinti, Mark
    Rondon, Juan Carlos
    Marbury, Thomas
    Tomlinson, Gareth
    Makris, Lukas
    Hangai, Nanae
    Wacheck, Volker
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (09): : 1713 - 1724
  • [24] PHARMACOKINETICS OF SETMELANOTIDE IN INDIVIDUALS WITH RENAL IMPAIRMENT: RESULTS FROM A PHASE 1, OPEN-LABEL, SINGLE-DOSE STUDY
    Zacchia, Miriam
    Navarria, Andrea
    Baughman, Sharon
    Roux, Willem
    Malhotra, Sonali
    Yuan, Guojun
    Cetiner, Metin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1133 - I1133
  • [25] Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination Tablet An Open-Label, Single-Dose Study in Healthy Chinese Subjects
    Chu, Nan-Nan
    Chen, Wei-Li
    Xu, Hong-Rong
    Li, Xue-Ning
    CLINICAL DRUG INVESTIGATION, 2012, 32 (12) : 791 - 798
  • [26] A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment
    Ou, Ying C.
    Preston, Richard A.
    Marbury, Thomas C.
    Tang, Zhiyu
    Novotny, William
    Tawashi, Manal
    Li, Ta-Kai
    Sahasranaman, Srikumar
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1355 - 1363
  • [27] Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects
    Chen, Qian
    Qian, Hong-jie
    Wang, Wei
    Zhang, Meng-qi
    Lu, Dong-ying
    Lu, Chuan
    Jin, Jie-mei
    Hu, Chao-ying
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Li, Xue-ning
    Yu, Chen
    Wang, Yi-ping
    Liu, Yun
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 120 - 125
  • [28] Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination TabletAn Open-Label, Single-Dose Study in Healthy Chinese Subjects
    Nan-Nan Chu
    Wei-Li Chen
    Hong-Rong Xu
    Xue-Ning Li
    Clinical Drug Investigation, 2012, 32 : 791 - 798
  • [29] Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study
    Jensen, Mathias Ebbesen
    Stenbaek, Dea Siggaard
    Messell, Catharina Dragsted
    Poulsen, Emil Deleuran
    Varga, Tibor V.
    Fisher, Patrick McDonald
    Nielsen, Marie Katrine Klose
    Johansen, Sys Stybe
    Volkow, Nora D.
    Knudsen, Gitte Moos
    Fink-Jensen, Anders
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025,
  • [30] Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers
    Wang, Shumin
    Wu, Feng
    Han, Ying
    Ni, Siyang
    Guo, Shaojie
    Dai, Yuyang
    Xia, Qiang
    Chang, Di
    Zhang, Ju
    Wei, Huiwen
    Zhao, Xiuli
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 949 - 956
12345